Oncopeptides has announced that Rolf Gulliksen has been appointed global head of corporate communications.
Rolf Gulliksen has 30 years of experience from senior corporate communications roles in the life science industry and consultancy. Prior to joining Oncopeptides, he served as head of corporate communications at Hansa Biopharma.
“Communication will be a critical function to support our growing business and presence in key markets and pave the way for our first potential commercial launch,” says Jakob Lindberg, CEO of Oncopeptides.
Gulliksen will be a member of Oncopeptides’ Management Team and will start immediately.